Lexology January 26, 2024
K&L Gates LLP

In anticipation of the US Food and Drug Administration (FDA) budget request for Fiscal Year (FY) 2025, this alert provides an overview of the agency’s most recent priorities as outlined in FDA’s FY 2024 budget, found here. This alert allows clients and stakeholders to review current year FDA priorities to indicate potential new areas of regulation and enforcement. The alert is part one of a two-part series and will be updated when the FDA releases its FY2025 priorities to identify changes in priorities from FY2024 to FY2025.

Broadly, FDA’s goals aim to enhance and expand FDA’s authority and oversight, as well as build upon and create new programs with regard to foods, dietary supplements, human and animal drugs, animal biologics,...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: FDA, Govt Agencies
5 Digital Health Areas To Be Impacted By The FDA Layoffs
FDA Approves First Biosimilar to Omalizumab
Trump's Nominees to Run FDA, NIH Get Greenlighted by Senate Committee
FDA Debuts a New Communications and Compliance Tool for Device Data Integrity Concerns
HHS Explores Stronger FDA Oversight for Food Ingredients

Share This Article